pMP71-hCD155 Citations (1)

Originally described in: TIGIT and PD-1 Mark Intratumoral T Cells with Reduced Effector Function in B-cell Non-Hodgkin Lymphoma.
Josefsson SE, Beiske K, Blaker YN, Forsund MS, Holte H, Ostenstad B, Kimby E, Koksal H, Walchli S, Bai B, Smeland EB, Levy R, Kolstad A, Huse K, Myklebust JH Cancer Immunol Res. 2019 Mar;7(3):355-362. doi: 10.1158/2326-6066.CIR-18-0351. Epub 2019 Jan 18. PubMed Journal

---

Articles Citing pMP71-hCD155

Articles
Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I. Murali TM, Li B, Hoos E, Collinson L, Long EO, Dushek O, Elliott T, Sim MJW. Discov Immunol. 2026 May 25;5(1):kyag010. doi: 10.1093/discim/kyag010. eCollection 2026. PubMed

If you have published an article using this material, please email us at to have your article added to this page.